| Title |
Agomelatine versus other antidepressive agents for major depression
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2013
|
| DOI | 10.1002/14651858.cd008851.pub2 |
| Pubmed ID | |
| Authors |
Giuseppe Guaiana, Sumeet Gupta, Debbie Chiodo, Simon JC Davies, Katja Haederle, Markus Koesters |
| Abstract |
Major depressive disorder (MDD), or depression, is a syndrome characterised by a number of behavioural, cognitive and emotional features. It is most commonly associated with a sad or depressed mood, a reduced capacity to feel pleasure, feelings of hopelessness, loss of energy, altered sleep patterns, weight fluctuations, difficulty in concentrating and suicidal ideation. There is a need for more effective and better tolerated antidepressants to combat this condition. Agomelatine was recently added to the list of available antidepressant drugs; it is a novel antidepressant that works on melatonergic (MT1 and MT2), 5-HT 2B and 5-HT2C receptors. Because the mechanism of action is claimed to be novel, it may provide a useful, alternative pharmacological strategy to existing antidepressant drugs. |
X Demographics
The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 12 | 43% |
| Argentina | 2 | 7% |
| France | 1 | 4% |
| United Kingdom | 1 | 4% |
| United States | 1 | 4% |
| Unknown | 11 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 79% |
| Practitioners (doctors, other healthcare professionals) | 4 | 14% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
| Scientists | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 387 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | <1% |
| Spain | 1 | <1% |
| India | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 382 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 63 | 16% |
| Student > Bachelor | 43 | 11% |
| Researcher | 42 | 11% |
| Student > Ph. D. Student | 35 | 9% |
| Student > Doctoral Student | 26 | 7% |
| Other | 74 | 19% |
| Unknown | 104 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 118 | 30% |
| Psychology | 40 | 10% |
| Nursing and Health Professions | 22 | 6% |
| Social Sciences | 20 | 5% |
| Agricultural and Biological Sciences | 15 | 4% |
| Other | 49 | 13% |
| Unknown | 123 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 May 2023.
All research outputs
#1,272,776
of 23,779,713 outputs
Outputs from Cochrane database of systematic reviews
#2,904
of 12,758 outputs
Outputs of similar age
#13,628
of 290,297 outputs
Outputs of similar age from Cochrane database of systematic reviews
#60
of 230 outputs
Altmetric has tracked 23,779,713 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,758 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,297 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 230 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.